Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.24% | 3.47% | -21.49% | -13.07% | 16.24% |
| Total Depreciation and Amortization | -7.09% | -0.91% | 3.17% | -3.51% | 1.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.74% | 51.85% | 30,077.78% | -101.61% | -24.02% |
| Change in Net Operating Assets | 227.75% | -289.64% | 159.91% | -15.70% | -459.82% |
| Cash from Operations | 44.94% | -28.81% | 19.79% | -18.52% | 2.61% |
| Capital Expenditure | 3.13% | 66.24% | -1,347.92% | -61.80% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 60.09% | 66.24% | -1,347.92% | -61.80% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.04% | 491.06% | -81.76% | 422.56% | 1,386.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -81.04% | 491.06% | -81.88% | 425.82% | 1,386.35% |
| Foreign Exchange rate Adjustments | 271.43% | -102.39% | 123.66% | 128.92% | -250.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -243.66% | 135.82% | -416.37% | 132.33% | 24.52% |